TAG Thoracic Endograft Approval Makes Gore First To Market In U.S.

By The Gray Sheet / “The Gray Sheet” Mar. 28, 2005, Vol. 31, No. 013
New Products / Word Count: 660 / Article # 01310130009

Executive Summary

Gore is negotiating with FDA the number of participants required for a post-approval study of TAG endoprosthesis to treat thoracic aortic aneurysms

Purchase this Article

$35.00 Buy Now

For $35.00, purchase this 660-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: TAG Thoracic Endograft Approval Makes Gore First To Market In U.S.

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to “The Gray Sheet” will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel

TAG Thoracic Endograft Approval Makes Gore First To Market In U.S.

Executive Summary

Purchase this Article

Already a Subscriber?

Questions?

Related Articles: 4

Elsevier Business Intelligence Publications

Offers & Events

Topics Covered in this Article

Email Article